Institutional Ownership Atara Biotherapeutics, Inc. (ATRA)
This table provides information about the institutional ownership of Atara Biotherapeutics, Inc. (ATRA). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 2.89 Million shares, which have been reported (via 13F filing form) to have a value of $21.7 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Kpcb Xv Associates, LLC
|
Oct 26, 2022 Q3 2022 |
1,876,650
shares
|
$13.3 Million
19.79% of portfolio
|
Q4 2020
New holding
|
|
|
Antipodean Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
1,000,000
shares
|
$7.11 Million
8.12% of portfolio
|
Q4 2021
Reduced 4.76%
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
4,500
shares
|
$31,995
0.0% of portfolio
|
Q4 2020
Reduced 75.0%
|
|
|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
3,079
shares
|
$21,891
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
900
shares
|
$6,399
0.0% of portfolio
|
Q3 2022
Reduced 90.22%
|
|
|
Ever Source Wealth Advisors, LLC
|
Feb 07, 2025 Q4 2024 |
35
shares
|
$248
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Alexis Investment Partners, LLC
Montgomery, TX |
Feb 13, 2025 Q4 2024 |
28
shares
|
$199
0.0% of portfolio
|
Q4 2024
New holding
|